MedPath

A novel maxillary injection technique to reduce the multiple injections

Phase 1
Completed
Registration Number
CTRI/2019/12/022215
Lead Sponsor
DrJArockia Antony Praveen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

1. Patients with age group of 18-70 years.

2. Patients with deep pockets (PPD>=5mm).

3. Patients who are undergoing Non-surgical periodontal therapies under local anaesthesia in maxilla.

4. Patients with ASA class â?  and â?¡.

Exclusion Criteria

1. Patients under analgesic, anti-inflammatory, anti-depressive medications.

2..Patients who are allergic to any of the local anesthetic drug.

3. Pregnant and lactating women.

4. Patients with bleeding disorders , neurological disorders.

5.Patients with missing upper premolars.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. The perception of numbness of palatal and buccal tissues. <br/ ><br> 2. Numbness of one entire maxillary quadrant. <br/ ><br>3.VAS score on pain perception.Timepoint: The duration and perception of anaesthesia is noted on after 5, 10, 20, 30, and 60 minutes.
Secondary Outcome Measures
NameTimeMethod
1.Pain on transgingival probing at one site in every tooth of the maxillary arch.(Pinprick test).Timepoint: The duration and perception of anaesthesia is noted on after 5, 10, 20, 30, and 60 minutes.
© Copyright 2025. All Rights Reserved by MedPath